Previous close | 2.3680 |
Open | 2.3680 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 2.3680 - 2.3680 |
52-week range | 2.0180 - 3.4320 |
Volume | |
Avg. volume | 1,147 |
Market cap | 3.874B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.04 (1.67%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | N/A |
Sumitomo Chemical Co., Ltd (TSE:4005), one of Japan's leading chemical companies, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new program to develop functional chemicals with synthetic biology and expand upon the companies' existing biomanufacturing partnership.